Hims & Hers (HIMS) Director David B. Wells Receives 778 RSUs

What Happened
David B. Wells, a director of Hims & Hers Health, Inc. (HIMS), was awarded 778 restricted stock units (RSUs) as director compensation in lieu of his Q2 2026 cash retainer. The award was reported on 2026-08-14; the grant used a per-share grant price of $30.40 and corresponds to foregone cash fees of $23,760 (per the filing footnote). The Form 4 lists an exercise/conversion (derivative) entry for 778 RSUs with acquisition and disposition amounts reported at $0.00 — this reflects RSU/derivative reporting and is not an open‑market sale.

Key Details

• Transaction date: 2026-08-14 (reported on Form 4 filed 2026-08-18).
• Award size: 778 RSUs. Grant price listed: $30.40. Footnote cites foregone cash fees of $23,760.
• Form shows conversion/exercise code (M) with both an acquisition and a corresponding disposal at $0.00 for 778 shares (see footnotes for RSU treatment).
• Vesting: RSUs will vest in full on the Company’s next quarterly vesting date (per filing).
• Shares owned after the transaction: not disclosed in the provided filing excerpt.
• No explicit late-filing flag provided in the excerpt.

Context

• RSUs are a contingent right to receive one share per RSU upon vesting; they are an award (compensation), not a market purchase or sale.
• The reported $0.00 disposal/acquisition lines typically reflect derivative/RSU reporting mechanics on Form 4 and do not indicate an open-market sale.
• Awards to non-employee directors in lieu of cash retainers are common and generally routine compensation, not necessarily a signal of insider sentiment.